George Bakris to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications George Bakris has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.259
-
Mineralocorticoid antagonists in chronic kidney disease. Curr Opin Nephrol Hypertens. 2017 01; 26(1):50-55.
Score: 0.141
-
Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy. Am J Nephrol. 2014; 40(1):64-74.
Score: 0.119